Publications

6434 items matching your search terms.

Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells

Fiddes, R. J.;Janes, P. W.;Sivertsen, S. P.;Sutherland, R. L.;Musgrove, E. A.;Daly, R. J. :

ONCOGENE 16 (21) :2803-13, 1998

Bone mass, lean mass, and fat mass: same genes or same environments?

Nguyen, T. V.;Howard, G. M.;Kelly, P. J.;Eisman, J. A. :

AMERICAN JOURNAL OF EPIDEMIOLOGY 147 (1) :3-16, 1998

Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis

Gough, A.;Sambrook, P.;Devlin, J.;Huissoon, A.;Njeh, C.;Robbins, S.;Nguyen, T.;Emery, P. :

JOURNAL OF RHEUMATOLOGY 25 (7) :1282-9, 1998

Replacement needs of pituitary mass

Ho, K. K. Y.; Webb, S. M.

Pituitary Tumours: Epidemiology, Pathogenesis and Management :165-174, 1998

Cell cycle controls in prostate cancer

Henshall, S.;Grygiel, J. J. :

Prostate Cancer Bulletin :4, 1998

Effect of continuous versus pulsatile GH administration on GH binding protein in man

Larsen, T.;Jorgensen, J. O. L.;Ho, K. K. Y.;Christiansen, J. S. :

Endocrinol Metab 4 :281-287, 1998

Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes

Markovic, T. P.;Campbell, L. V.;Balasubramanian, S.;Jenkins, A. B.;Fleury, A. C.;Simons, L. A.;Chisholm, D. J. :

DIABETES CARE 21 (5) :695-700, 1998

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival

Hui, R.;Ball, J. R.;Macmillan, R. D.;Kenny, F. S.;Prall, O. W.;Campbell, D. H.;Cornish, A. L.;McClelland, R. A.;Daly, R. J.;Forbes, J. F.;Blamey, R. W.;Musgrove, E. A.;Robertson, J. F.;Nicholson, R. I.;Sutherland, R. L. :

ONCOGENE 17 (8) :1053-9, 1998

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

Workshop, G. R. S. :

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 83 (2) :379-81, 1998

Genes and osteoporosis

White, C.; Eisman, J.; Geusens, P.

Osteoporosis in clinical practice 7 :37-40, 1998

Galanin receptors: recent developments and potential use as therapeutic targets

Fathi, Z.;Church, W. B.;Iismaa, T. P. :

Annual Reports in Medicinal Chemistry 33 :41-50, 1998

Mouse prolactin receptor gene: genomic organization reveals alternative promoter usage and generation of isoforms via alternative 3'-exon splicing

Ormandy, C. J.;Binart, N.;Helloco, C.;Kelly, P. A. :

DNA AND CELL BIOLOGY 17 (9) :761-70, 1998

Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3

Fiddes, R. J.;Campbell, D. H.;Janes, P. W.;Sivertsen, S. P.;Sasaki, H.;Wallasch, C.;Daly, R. J. :

JOURNAL OF BIOLOGICAL CHEMISTRY 273 (13) :7717-24, 1998

Ritonavir has paradoxical effects on lipid metabolism and insulin sensitivity in rats compared with humans

Ye, J. M.;Samaras, K.;Bonner, K. M.;Cooney, G. J.;Chisholm, D. J.;Kraegen, E. W. :

AIDS 12 (16) :2236-7, 1998

Galanin regulates prolactin release and lactotroph proliferation

Wynick, D.;Small, C. J.;Bacon, A.;Holmes, F. E.;Norman, M.;Ormandy, C. J.;Kilic, E.;Kerr, N. C.;Ghatei, M.;Talamantes, F.;Bloom, S. R.;Pachnis, V. :

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 95 (21) :12671-6, 1998

Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity

Ruderman, N. B.;Saha, A. K.;Vavvas, D.;Kurowski, T.;Laybutt, D. R.;Schmitz-Peiffer, C.;Biden, T.;Kraegen, E. W. :

Advances in Experimental Medicine and Biology 441 :263-70, 1998